and the Musculoskeletal Transplant Foundation (MTF ).com.

Forward-Looking Statements
The statements contained in this press release that are not purely
historical are forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended , and are intended to be covered by the safe
harbors created thereby.

physiological xrt

Dr.

VirtualScopics Analytical Tools Used to Study Restoration of Dead Bone

VirtualScopics' suite of proprietary software analysis tools demonstrated
dramatic revascularization of the bone from the baseline imaging session to
the first follow-up.

borescope tomography

ROCHESTER, N. The
firm's proprietary software algorithms can assemble hundreds of separate
medical images taken during an MRI session into a single, three-dimensional
model , bringing a new and previously unobtainable source of data to clinical
researchers.

contrast commercialization

Unlike other paramagnetic
contrast agents, MultiHance demonstrates weak and transient
interactions with serum proteins resulting in strong increases in
relaxivity in solutions containing serum proteins.

confocal lapse

(OTC Bulletin Board: VSCP), a leading developer of image-related biomarkers,
today announced that its analysis tools for Dynamic Contrast Enhanced-Magnetic
Resonance Imaging (DCE-MRI) revealed bone restoration in a pilot study with
LAGeT Inc. Founded in 2001, LAGeT is focused on the commercialization of the
LAGT technology, a novel gene delivery device.

metallographical biometric

Bracco Diagnostics Delivers First MultiHance to Dr. Martin Prince of Weill Cornell MRI

Prince's Research Efforts

Bracco Diagnostics Inc . Martin Prince of Weill Cornell MRI, who
played a key role in the development and research of the product.
Bracco also operates a high-level international research network,
with three centers (Milan, Geneva, and Princeton).
"VirtualScopics DCE-MRI analysis will be the primary outcome measurement
in a larger LAGeT-MTF clinical trial to evaluate the 'Revascularizing
Allograft', " said Dr.

xrt imaging

Business Editors/Health/Medical Writers

NEW YORK----

Bracco CEO Makes Symbolic Personal Delivery to Mark
Recent FDA Approval, Acknowledge Dr.
"We are tremendously proud to have received FDA approval for
MultiHance, and we certainly recognize the visionary influence Dr.
This pilot animal study allowed the research team to determine the imaging
technique feasibility including subject positioning and image reconstruction
in an area of bone healing where an implant is present. Due to the pilot's
success, a larger study is planned which involves functional in vivo imaging
to evaluate the efficacy of a novel gene therapy to enhance allograft
incorporation . Factors that could cause or contribute to such differences
include, but are not limited to, those discussed from time to time in reports
filed by the Company with the Securities and Exchange Commission .

confocal mulgrave

He holds 26 patents, and is Professor
of Radiology at Weill Medical College of Cornell University and Chief
of MRI at NewYork-Presbyterian Hospital/Weill Cornell. Bracco
has operations in 115 countries and about 3,500 employees, over 600 of
whom work in R+D.

The generic issues of imaging science include image-data acquisition; image reconstruction and processing; image recording and distribution; image display, analysis, and evaluation; human vision; and the mental processes involved in observation .

poynton rigorously

Edward Schwarz, president of LAGeT, Inc. is a provider of advanced medical image analysis
services.

CONTACT:
Tracy Bagatelle-Black
Bagatelle-Black Public Relations
661/263-1842
tracy@bagatelleblack.

microscope observe

MultiHance was recently approved by the United States Food + Drug
Administration, and is indicated for use in Magnetic Resonance Imaging
(MRI ) of the central nervous system in adults to visualize lesions
with abnormal blood brain barrier or abnormal vascularity of the
brain, spine and associated tissues."

About Bracco

The Bracco Group is a world-leading provider of global diagnostic
imaging solutions, with net sales of more than $1. "Worldwide, VirtualScopics has the only
regulatory compliant software tools that could have measured this positive
study outcome, and we look forward to a larger clinical trial. For more information about VirtualScopics, visit
http://www.

lapse mulgrave

President and Chief Executive Officer
Carlo Medici personally delivered the first commercial shipment of
recently FDA-approved MultiHance(R) (gadobenate dimeglumine)
injection, 529 mg/ml, to Dr.

Package Insert is available upon request ."
In this study, a canine test subject received a bone allograft and was
subsequently studied using DCE-MRI over three time-points following surgery.

About VirtualScopics, Inc.

Imaging science is a relatively new discipline that combines computer-based imaging techniques with a variety of data acquisition tools to increase the range of properties that scientists can observe.

lapse confocal

25 billion .
The possibility of a reaction, including serious,
life-threatening, or fatal, anaphylactic or cardiovascular reactions,
or other idiosyncratic reactions, should always be considered,
especially in those patients with a history of known clinical
hypersensitivity or a history of asthma or allergic respiratory
disorders.

poynton improves

We
are pleased that our tools were instrumental in successfully demonstrating
bone revascularization [restoration] over time," said Bob Klimasewski,
president and CEO of VirtualScopics .

commercialization poynton

These centers
develop products of the latest-generation diagnostic techniques, from
X-ray and computed tomography (CT) to magnetic resonance imaging
(MRI), nuclear medicine and ultrasound. The Company recently closed
its first financing round, part of which is being used to fund the development
of the LAGT prototype gene activation system.

rigorously ornl

lapse poynton

metallographical confocal

Prince specializes in body MRI and MR angiography, and is
internationally recognized for his pioneering work in developing
Magnetic Resonance techniques . "When you reflect on the
transformation of a concept into a viable, proven, and approved MRI
contrast agent that will no doubt change the MRI arena, it is clear
how important collaborative relationships are among corporate,
research, academic, and clinical opinion leaders. Bracco invests approximately 15% of its annual
turnover in R+D and has a portfolio of 1,500 patents worldwide. Forward-looking statements deal with the Company's
current plans, intentions, beliefs and expectations.

radiography layering

VirtualScopics , Inc. The company evolved from research first carried out at the
University of Rochester Medical Center and School of Engineering.

mammography borescope

virtualscopics.

metallographical commercialization

An allograft is a graft of tissue or an organ transplant between a donor and a
recipient who are of the same species but genetically unlike.
LAGeT , Inc.

resonance rigorously

While Bracco is recognized internationally as a definitive
market leader in its core business of contrast media, Bracco also
markets key diagnostic imaging resources through the following
companies: Esaote, which is one of the world's primary producers of
magnetic resonance and ultrasound imaging systems; ACIST Medical
Systems, a manufacturer of advanced contrast media injection systems;
EBIT -AET, which creates and markets medical application software, and
Singapore-based Volume Interactions , which also produces advanced
medical software., VirtualScopics, Inc. In the
future, VirtualScopics ' technology will enable clinicians to utilize a non-
invasive method of quantifying the extent of restoration of bone through
longitudinal clinical trials.

lapse mammography

The improved
relaxation effect could potentially contribute to improved
visualization.
The Bracco Group is a leader in the diagnostic imaging market with
an integrated product offering from a diverse roster of subsidiary
companies .

About MultiHance

As with all paramagnetic agents, caution should be exercised in
patients with deoxygenated sickle erythocytes. is a Rochester, NY-based, privately held biotechnology
company .com

commercialization biometric

We are here to
congratulate and thank Dr. Prince for that collaboration. A bone
allograft can potentially stimulate the body into restoring dead bone to life. Investors are cautioned
that all forward-looking statements involve risks and uncertainties that could
cause actual results to differ materially from those in the forward-looking
statements.

borescope xrt

About LAGeT, Inc .
VirtualScopics has created a suite of image analysis tools used in detecting
and analyzing specific structures in volumetric medical images, as well as
characterizing minute changes in structures over time, providing vital
information to support clinical trials and diagnostic applications.

physiological mammography

Prince had on the process," said Medici.Y.
"This milestone study represents a year of work with LAGeT and MTF.

commercialization confocal